Johnson & Johnson Announces a Lead COVID-19 Vaccine Candidate
FDA Accelerates Review of COVID-19 Diagnostic Tests
Bristol Myers Scores FDA Approval for Celgene’s MS Drug Ozanimod
FDA Approves Prescription Digital Therapeutic for Chronic Insomnia
How the Pharmaceutical Industry Is Approaching a COVID-19 Vaccine
Gilead Requests FDA to Rescind Orphan Drug Status for Remdesivir
CVS Caremark Implements Measures to Protect COVID-19 Supply Chain
Revamping Biosimilar Reviews to Spur Drug Development in Oncology
Suppliers Unable to Meet Orders for Potential COVID-19 Drugs
Vivli Launches COVID-19 Portal to Share Clinical Trial Data
Graphics Processing Units Tech to Accelerate COVID-19 Sequencing
HHS Funds Clinical Trial for Potential COVID-19 Treatment
Gilead Halts Access to Potential COVID-19 Drug Remdesivir
COVID-19 Concerns at US Clinical Trial Sites Jump 88% Over 4 Days
Lopinavir- Ritonavir Not Effective in Adults with Severe COVID-19
Court Tells Mallinckrodt to Pay $650M in Back Medicaid Rebates
FDA Approves Roche’s Biomarker Test for At-Risk HPV Infections
GSK, Chapel-Hill Renew $20M Partnership to Discover HIV Treatment
MassBio, Bayer Launch Center for Startups in the Biotech Space
FDA Proposes Broad Approach to Clinical Trials for Diabetes Drugs
FDA Authorizes Additional COVID-19 Testing in New York
Phase 1 Clinical Trial for Coronavirus Vaccine Begins in Seattle
Patients Benefiting from Immune Checkpoint Inhibitor Drugs Limited
Latest Coronavirus Updates for the Healthcare Community
Major NY Opioid Trial in Delayed Due to COVID-19 Concerns
Pharmacy Benefit Managers Prepared to Tackle COVID-19
Cell and Gene Therapy Development Increased 20%, PhRMA Finds
$125M Initiative to Boost Drug Discovery for COVID-19 Treatment
FDA, FTC Warn Companies to Stop Selling Fraudulent COVID-19 Drugs
First Gene Therapy Clinical Trial to Address Genetic Blindness
FDA Provides Coronavirus Supply Chain Update
Prescription Drug Prices Spike Following FDA Approval, Study Finds
Gene Therapy, Regenerative Medicine Markets Booming Worldwide
FDA Approves First Generic Drug Version of Daraprim
Pharma Companies Spent $985M On New Drug Development
Feds Charge Sandoz for Fixing Generic Drug Prices
New Ruling to Expand Public Access to Clinical Trial Data
Former SARS, MERS Drug Could Treat COVID-19 Patients
Sanofi to Pay $11.85M to Resolve Medicare Fraud Allegations
Prescription Drug Costs Increased 3X Over the Past Decade
Policymakers Call Out Express Scripts Over Rising Insulin Prices
ICER: New Migraine Drugs Not as Expensive as Previously Thought
CA Firm Files Wrongful Death Lawsuit Over Opioid Dependence Drug
Pharma Company Earns $311M for Cannabinoid Medicines
What the New Coronavirus Means for the Pharmaceutical Industry